The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12

被引:105
|
作者
Lupardus, Patrick J.
Garcia, K. Christopher [1 ]
机构
[1] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
IL-23; IL-12; cytokine; receptor; crystallography;
D O I
10.1016/j.jmb.2008.07.051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin (IL)-23 is a recently identified member of the IL-12 family of heterodimeric cytokines that modulate subpopulations of T helper cells, and both IL-12 and IL-23 are attractive targets for therapy of autoimmune diseases. IL-23 is a binary complex of a four-helix bundle cytokine (p19) and a soluble class I cytokine receptor p40. IL-12 and IL-23 share p40 as an alpha-receptor subunit, yet show only 15% sequence homology between their four-helix cytokines p19 and p35, respectively, and signal through different combinations of shared receptors. In order to elucidate the structural basis of p40 sharing, we have determined a 2.3-angstrom crystal structure of IL-23 for comparison to the previously determined structure of IL-12. The docking mode of p19 to p40 is altered compared to p35, deviating by a tilt and roll that results in an altered footprint of p40 on the A and D helices of the respective cytokines. Binding of p19 to p40 is mediated primarily by an arginine residue on helix D of p19 that forms an extensive charge and hydrogen-bonding network with residues at the base of a pocket on p40. This 'arginine pocket' is lined with an inner shell of hydrophobic interactions that are ringed by an outer shell of polar interactions. Comparative analysis indicates that the IL-23 and IL-12 complexes 'mimic' the network of interactions constituting the central arginine pocket despite p19 and p35 having limited sequence homology. The majority of the structural epitopes in the two complexes are composed of unique p19 and p35 pairwise contacts with common residues on p40. Thus, while the critical hotspot is maintained in the two complexes, the majority of the interfaces are structurally distinct and, therefore, provide a basis for the therapeutic targeting of IL-12 versus IL-23 heterodimer formation despite their use of a common receptor subunit. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:931 / 941
页数:11
相关论文
共 50 条
  • [11] Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo
    Gately, MK
    Carvajal, DM
    Connaughton, SE
    Gillessen, S
    Warrier, RR
    Kolinsky, KD
    Wilkinson, VL
    Dwyer, CM
    Higgins, GF
    Podlaski, FJ
    Faherty, DA
    Familletti, PC
    Stern, AS
    Presky, DH
    INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 : 1 - 12
  • [12] Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits
    Wang, X
    Wilkinson, VL
    Podlaski, FJ
    Wu, CY
    Stern, AS
    Presky, DH
    Magram, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (06) : 2007 - 2013
  • [13] Astrocytes and microglia produce interleukin-12 p40
    Constantinescu, CS
    Frei, K
    Wysocka, M
    Trinchieri, G
    Malipiero, U
    Rostami, A
    Fontana, A
    INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 : 328 - 333
  • [14] Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis
    Gandhi, Mona
    Alwawi, Eihab
    Gordon, Kenneth B.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2010, 29 (01) : 48 - 52
  • [15] Blocking Interleukin-12 and Interleukin-23 in the Treatment of Axial Spondyloarthritis
    Denis Poddubnyy
    Current Treatment Options in Rheumatology, 2015, 1 (2) : 231 - 238
  • [16] Genetic evidence for the existence of interleukin-23 and for variation in the interleukin-12 and interleukin-12 receptor genes in the horse
    Kralik, Petr
    Matiasovic, Jan
    Horin, Petr
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY D-GENOMICS & PROTEOMICS, 2006, 1 (02): : 179 - 186
  • [17] Interleukin-12 p40 polymorphism and susceptibility to multiple sclerosis
    Alloza, I
    Heggarty, S
    Goris, A
    Graham, CA
    Dubois, B
    McDonnell, G
    Hawkins, SA
    Carton, H
    Vandenbroeck, K
    ANNALS OF NEUROLOGY, 2002, 52 (04) : 524 - 525
  • [18] The Expression of Interleukin-23 (p19/p40) and Inteleukin-12 (p35/p40) in Psoriasis Skin
    陈旭娥
    谭志建
    岳青
    刘厚君
    刘志香
    李家文
    华中科技大学学报(医学英德文版), 2006, (06) : 750 - 752
  • [19] INTERLEUKIN-23, BUT NOT INTERLEUKIN-12, DRIVES MURINE AUTOREACTIVITY TO THE GOODPASTURE ANTIGEN
    Ooi, J.
    Holdsworth, S.
    Kitching, A. R.
    NEPHROLOGY, 2008, 13 : A140 - A140
  • [20] Erythema multiforme during treatment with interleukin-12 and interleukin-23 inhibitor
    Bogucki, Pawel
    Downs, Anthony
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB199 - AB199